Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective naturalistic clinical trial with loxapine in agitated patients with personality disorder
2016-004884-38Phase 4Completed
- Sponsor
- Vall d'Hebron University Hospital
- Start
- Jul 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of loxapine in personality disorder (PD), sponsored by Vall d'Hebron University Hospital. Primary endpoints: Clinical Global Impression-Improvement (CGI-I) response, Excited Component of the Positive and Negative Syndrome Scale (PANSS-EC) and 1 more. Started Jul 2017; status: completed.
02
Drugs
loxapine
03
Conditions
personality disorder (PD)
Beyond the preview
Go deeper on 2016-004884-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004884-38.